Chemistry Reference
In-Depth Information
Koegl M, Hoppe T, Schlenker S et al (1999) A novel ubiquitination factor, E4, is involved in mul-
tiubiquitin chain assembly. Cell 96:635-644
Kosik KS, Shimura H (2005) Phosphorylated tau and the neurodegenerative foldopathies. Bio-
chim Biophys Acta 1739:298-310
Kriegenburg F, Ellgaard L, Hartmann-Petersen R (2012) Molecular chaperones in targeting mis-
folded proteins for ubiquitin-dependent degradation. FEBS J 279:532-542
Kundrat L, Regan L (2010a) Balance between folding and degradation for Hsp90-dependent client
proteins: a key role for CHIP. Biochemistry 49:7428-7438
Kundrat L, Regan L (2010b) Identification of residues on Hsp70 and Hsp90 ubiquitinated by the
cochaperone CHIP. J Mol Biol 395:587-594
Landry SJ, Gierasch LM (1994) Polypeptide interactions with molecular chaperones and their
relationship to
in vivo
protein folding. Annu Rev Biophys Biomol Struct 23:645-669
Lecker SH, Goldberg AL, Mitch WE (2006) Protein degradation by the ubiquitin-proteasome
pathway in normal and disease states. J Am Soc Nephrol 17:1807-1819
Lee I, Schindelin H (2008) Structural insights into E1-catalyzed ubiquitin activation and transfer
to conjugating enzymes. Cell 134:268-278
Li F, Xie P, Fan Y et al (2009) C terminus of Hsc70-interacting protein promotes smooth muscle
cell proliferation and survival through ubiquitin-mediated degradation of FoxO1. J Biol Chem
284:20090-20098
Li J, Soroka J, Buchner J (2012) The Hsp90 chaperone machinery: conformational dynamics and
regulation by co-chaperones. Biochim Biophys Acta 1823:624-635
Loffek S, Woll S, Hohfeld J et al (2010) The ubiquitin ligase CHIP/STUB1 targets mutant keratins
for degradation. Hum Mutat 31:466-476
Lotz GP, Lin H, Harst A et al (2003) Aha1 binds to the middle domain of Hsp90, contributes to
client protein activation, and stimulates the ATPase activity of the molecular chaperone. J Biol
Chem 278:17228-17235
Luders J, Demand J, Hohfeld J (2000) The ubiquitin-related BAG-1 provides a link between the
molecular chaperones Hsc70/Hsp70 and the proteasome. J Biol Chem 275:4613-4617
Luo W, Zhong J, Chang R et al (2010) Hsp70 and CHIP selectively mediate ubiquitination and
degradation of hypoxia-inducible factor (HIF)-1alpha but Not HIF-2alpha. J Biol Chem
285:3651-3663
Mao Y, Deng A, Qu N et al (2006) ATPase domain of Hsp70 exhibits intrinsic ATP-ADP exchange
activity. Biochemistry (Mosc) 71:1222-1229
Marques C, Guo W, Pereira P et al (2006) The triage of damaged proteins: degradation by the
ubiquitin-proteasome pathway or repair by molecular chaperones. FASEB J 20:741-743
Martin L, Latypova X, Terro F (2011) Post-translational modifications of tau protein: implications
for Alzheimer's disease. Neurochem Int 58:458-471
Maruyama T, Kadowaki H, Okamoto N et al (2010) CHIP-dependent termination of MEKK2
regulates temporal ERK activation required for proper hyperosmotic response. EMBO J
29:2501-2514
Matsumura Y, Sakai J, Skach WR (2013) Endoplasmic reticulum protein quality control is deter-
mined by cooperative interactions between Hsp/c70 protein and the CHIP E3 ligase. J Biol
Chem 288:31069-31079
McDonough H, Patterson C (2003) CHIP: a link between the chaperone and proteasome systems.
Cell Stress Chaperones 8:303-308
McLaughlin SH, Smith HW, Jackson SE (2002) Stimulation of the weak ATPase activity of human
hsp90 by a client protein. J Mol Biol 315:787-798
McLellan CA, Raynes DA, Guerriero V (2003) HspBP1, an Hsp70 cochaperone, has two struc-
tural domains and is capable of altering the conformation of the Hsp70 ATPase domain. J Biol
Chem 278:19017-19022
Meacham GC, Patterson C, Zhang W et al (2001) The Hsc70 co-chaperone CHIP targets immature
CFTR for proteasomal degradation. Nat Cell Biol 3:100-105
Medeiros R, Baglietto-Vargas D, LaFerla FM (2011) The role of tau in Alzheimer's disease and
related disorders. CNS Neurosci Ther 17:514-524
Search WWH ::
Custom Search